March 25, 2026

When Guillain-Barré Signals Lyme 

A case highlights how evolving neurologic findings can prompt testing for tick-borne infection.

Conexiant

March 25, 2026

Tau Biomarker Expands Beyond Alzheimer’s

Study finds elevated phosphorylated tau in AL and ATTR amyloidosis, suggesting a potential blood biomarker for amyloid-related neuropathy

The Pathologist

March 25, 2026

CAR-Engineered Astrocytes in Alzheimer’s Models

Preclinical findings show engineered astrocytes reduce amyloid buildup in mouse models and demonstrate a potential therapeutic approach

The Medicine Maker

March 24, 2026

Mammography AI Spots Vascular Signals

Routine breast imaging offers opportunity for cardiovascular risk assessment.

Conexiant

March 24, 2026

Floaters May Signal Higher Risk Than Flashes

New study examines retinal detachment risk in primary care presentations

Conexiant

March 23, 2026

MRI Identifies 3 Friedreich Ataxia Subtypes

Machine learning analysis of structural MRI reveals distinct patterns of neurodegeneration that vary in their association with disease severity

Conexiant

March 23, 2026

Researchers Propose TMD Definition for GBD

Consensus description may support inclusion in Global Burden of Disease estimates.

Conexiant

March 23, 2026

Menopause: More Cognitive Complaints, Not Decline

Subjective complaints increase during the menopause transition, while measurable cognitive performance shows little overall change.

Conexiant

March 23, 2026

Influencer Drug Promotion Raises Concerns

Study highlights regulatory gaps and persuasive risks in social media marketing

Conexiant

March 23, 2026

Fibromyalgia Drugs Tested for Value

Investigators compare common fibromyalgia therapies.

Conexiant